An Open-label Phase 1b Study of ARQ 092 in Combination with Other Antineoplastic Agents in Subjects with Selected Solid Tumors
The goal of this clinical research study is to learn if the combination of anastrozole and ARQ-092 can help to control endometrial cancer. The safety of this drug combination will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 10/19/2018
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: